Sponsor:
NRG Oncology
Code:
NCT05174169
Conditions
Stage III Colon Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Signatera test
mFOLFOX6 3-6 month
CAPOX 3 month
mFOLFIRINOX
mFOLFOX6 6 month
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by NRG Oncology on 2025-03-25.